• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素在运动障碍中的应用

Botulinum toxin in movement disorders.

作者信息

Tater Priyanka, Pandey Sanjay

机构信息

Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India.

出版信息

Neurol India. 2018 Mar-Apr;66(Supplement):S79-S89. doi: 10.4103/0028-3886.226441.

DOI:10.4103/0028-3886.226441
PMID:29503330
Abstract

Botulinum toxin has gained immense popularity since its introduction for therapeutic use. It is used in a variety of movement disorders like hemi-facial spasm, focal dystonias like blepharospasm, cervical dystonia, oromandibular dystonia, limb dystonias. It is also being used in patients with tremors, tics and for a variety of indications in Parkinson's disease as well. There are eight subtypes of toxins available, but type A and B are the ones used in movement disorder clinics. The toxin mainly acts by inhibiting the release of acetylcholine at the neuromuscular junction and causing weakness. Type B toxin has more effect over the autonomic nervous system and hence is preferred for hyper-secretory disorders. The use of electromyography and ultrasound further improve the accuracy of the procedure. It is a relatively safe therapeutic option with its effect lasting for around three months. It has very few side effects. The key is to start with the lowest possible dose and then gradually increase the dose depending upon the patient's response. Selecting the right muscles for injection is of utmost importance and is guided by the knowledge of anatomy of the muscles.

摘要

自肉毒杆菌毒素被引入用于治疗以来,它已广受欢迎。它被用于多种运动障碍,如半面痉挛、局灶性肌张力障碍,如眼睑痉挛、颈部肌张力障碍、口下颌肌张力障碍、肢体肌张力障碍。它也被用于震颤、抽搐患者以及帕金森病的多种适应症。有八种毒素亚型可供使用,但A 型和B型是运动障碍诊所使用的类型。该毒素主要通过抑制神经肌肉接头处乙酰胆碱的释放并导致肌无力起作用。B型毒素对自主神经系统有更大作用,因此更适合用于分泌过多性疾病。肌电图和超声的使用进一步提高了该操作的准确性。它是一种相对安全的治疗选择,其效果持续约三个月。它的副作用很少。关键是从尽可能低的剂量开始,然后根据患者的反应逐渐增加剂量。选择正确的注射肌肉至关重要,这由肌肉解剖学知识指导。

相似文献

1
Botulinum toxin in movement disorders.肉毒杆菌毒素在运动障碍中的应用
Neurol India. 2018 Mar-Apr;66(Supplement):S79-S89. doi: 10.4103/0028-3886.226441.
2
[Treatment of movement disorders using botulinum toxin].[使用肉毒杆菌毒素治疗运动障碍]
Schweiz Med Wochenschr. 1992 Sep 5;122(36):1311-6.
3
Botulinum toxin in movement disorders.肉毒杆菌毒素在运动障碍中的应用。
Semin Neurol. 2007 Apr;27(2):183-94. doi: 10.1055/s-2007-971171.
4
An update on new and unique uses of botulinum toxin in movement disorders.肉毒杆菌毒素在运动障碍中的新独特用途的最新进展。
Toxicon. 2018 Jun 1;147:84-88. doi: 10.1016/j.toxicon.2017.09.003. Epub 2017 Sep 6.
5
Botulinum toxin for the treatment of movement disorders.肉毒毒素治疗运动障碍。
Curr Neurol Neurosci Rep. 2012 Aug;12(4):399-409. doi: 10.1007/s11910-012-0286-3.
6
Botulinum toxin in clinical practice.临床实践中的肉毒杆菌毒素。
Drugs. 1994 Dec;48(6):888-93. doi: 10.2165/00003495-199448060-00005.
7
Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.低剂量Dysport肉毒杆菌毒素治疗局灶性运动障碍的五年经验。
Muscle Nerve. 1995 Jul;18(7):720-9. doi: 10.1002/mus.880180708.
8
Consensus statement for the management of focal dystonias.局灶性肌张力障碍管理的共识声明。
Br J Hosp Med. 1993;50(11):655-9.
9
Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.肉毒毒素治疗口颌面部肌张力障碍和口腔颌面部运动障碍。
Toxins (Basel). 2022 Apr 14;14(4):282. doi: 10.3390/toxins14040282.
10
Botulinum Toxin in Movement Disorders: An Update.肉毒毒素在运动障碍中的应用:最新进展。
Toxins (Basel). 2021 Jan 8;13(1):42. doi: 10.3390/toxins13010042.

引用本文的文献

1
Botulinum toxin treatment for hemifacial spasm: harmonising neurological and aesthetic outcomes.肉毒杆菌毒素治疗面肌痉挛:协调神经学和美学效果。
J Neural Transm (Vienna). 2025 Jan;132(1):23-38. doi: 10.1007/s00702-024-02821-y. Epub 2024 Aug 23.
2
Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.A型肉毒毒素注射治疗Meige 综合征的疗效。
Arq Neuropsiquiatr. 2024 Apr;82(4):1-7. doi: 10.1055/s-0044-1785691. Epub 2024 Apr 19.
3
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.
欧洲抽动秽语综合征和其他抽动障碍临床指南 2.0 版。第三部分:药物治疗。
Eur Child Adolesc Psychiatry. 2022 Mar;31(3):425-441. doi: 10.1007/s00787-021-01899-z. Epub 2021 Nov 10.
4
The Use of Botulinum Toxin A as an Adjunctive Therapy in the Management of Chronic Musculoskeletal Pain: A Systematic Review with Meta-Analysis.A型肉毒毒素辅助治疗慢性肌肉骨骼疼痛的应用:系统评价与荟萃分析。
Toxins (Basel). 2021 Sep 10;13(9):640. doi: 10.3390/toxins13090640.
5
Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.肉毒杆菌神经毒素治疗帕金森病自主症状的应用:最新综述。
Toxins (Basel). 2021 Mar 19;13(3):226. doi: 10.3390/toxins13030226.
6
Use of botulinum toxin for movement disorders.肉毒杆菌毒素在运动障碍中的应用。
Drugs Context. 2019 Jun 18;8:212586. doi: 10.7573/dic.212586. eCollection 2019.
7
Imaging of masseter muscle spasms by ultrasonography: a preliminary study.超声检查咬肌痉挛的影像学表现:一项初步研究。
Oral Radiol. 2020 Jan;36(1):85-88. doi: 10.1007/s11282-019-00383-4. Epub 2019 Apr 8.